BioSpace - Inspire Pharmaceuticals, Inc. News, Search Jobs, Events

BioSpace Login

Enter your BioSpace account email address and password to log in now.

Email Address

Password

Keep me logged in

Close Window

Forgot Your Password? | Privacy Statement

NEW MEMBER SIGN UP

Display Name

Email Address

Password

Password again

Zip

Country

Close Window

Privacy Statement

BioSpace.com

Biotech and Pharmaceutical
News & Jobs

Search the Site

Community Login

What is this?

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile

Inspire Pharmaceuticals, Inc.

4222 Emperor Boulevard
Suite 200
Durham North Carolina 27703 U.S.A.
Phone: 919-941-9777 Fax: 919-941-9797

View Clinical Trials from BioPharm Insight

Inspire is a biopharmaceutical company focused on researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire’s goal is to build and commercialize a sustainable portfolio of innovative new products based on its technical and scientific expertise. The most advanced compounds in Inspire’s clinical pipeline are Prolacria™ for dry eye and denufosol tetrasodium for cystic fibrosis, which are both in Phase 3 development, and AzaSite® for blepharitis, which is in Phase 2 development. Inspire receives revenues related to the promotion of AzaSite for bacterial conjunctivitis, co-promotion of Elestat® for allergic conjunctivitis and royalties based on net sales of Restasis® for dry eye.

For more information, visit www.inspirepharm.com.

Key Statistics

Email: info@inspirepharm.com
Ownership:
Web Site: Inspire Pharmaceuticals, Inc.
Employees:
Symbol: ISPH

Industry
Biotechnology
Biopharmaceutical

Segment
Human Therapeutics

Company News

EquipNet, Inc. Release: November 12 Webcast Auction with Great Deals on Lab/Pharma Equipment; Massive Inventory of Late-Model Surplus Equipment from Adolor Corporation (ADLR) And Inspire Pharmaceuticals, Inc. (ISPH) 11/12/2009 1:57:03 PM More...

Inspire Pharmaceuticals, Inc. (ISPH) Reports Third Quarter 2009 Financial Results 11/5/2009 9:41:52 AM More...

Inspire Pharmaceuticals, Inc. (ISPH) Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis 11/4/2009 9:31:44 AM More...

Inspire Pharmaceuticals, Inc. (ISPH) Announces Date for Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results 10/22/2009 9:39:52 AM More...

Inspire Pharmaceuticals, Inc. (ISPH)'s President and CEO Christy Shaffer Receives Cystic Fibrosis Foundation's Highest Award 10/20/2009 8:53:32 AM More...

Inspire Pharmaceuticals, Inc. (ISPH) Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial 10/15/2009 8:30:16 AM More...

InSite Vision (ISV)'s Partner Inspire Pharmaceuticals, Inc. (ISPH)'s AzaSite(R) Production Increased in Response to Erythromycin Ophthalmic Ointment Shortage 9/15/2009 10:02:40 AM More...

Inspire Pharmaceuticals, Inc. (ISPH) Committed to Helping Healthcare Providers and Patients During Erythromycin Ophthalmic Ointment Shortage 9/10/2009 10:46:20 AM More...

Inspire Pharmaceuticals, Inc. (ISPH) Announces Webcasts Of Presentations At Morgan Stanley, Biocentury And UBS Healthcare Conferences 9/9/2009 1:49:48 PM More...

Inspire Pharmaceuticals, Inc. (ISPH) Wins North Carolina Health & Life Sciences Award for Cystic Fibrosis Development Program 9/9/2009 9:54:59 AM More...

1